{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:41:36Z","timestamp":1790257296986,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.neurobiolaging.2012.01.015","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T02:10:15Z","timestamp":1330999815000},"page":"2798-2806","source":"Crossref","is-referenced-by-count":45,"title":["Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia"],"prefix":"10.1016","volume":"33","author":[{"given":"Simone","family":"Guadagna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Esiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib1","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1073\/pnas.91.12.5562","article-title":"Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease","volume":"91","author":"Alonso","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1212\/WNL.42.9.1681","article-title":"Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-328X(95)00111-5","article-title":"Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: implication of phosphoprotein phosphatase involvement","volume":"34","author":"Baum","year":"1995","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib5","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","article-title":"Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding","volume":"10","author":"Bramblett","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Buee","year":"2000","journal-title":"Brain Res. Brain Res. Rev"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.neurobiolaging.2005.03.003","article-title":"In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors","volume":"27","author":"De Sarno","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000107099","article-title":"Reduction of phosphorylated tau during memantine treatment of Alzheimer's disease","volume":"24","author":"Degerman Gunnarsson","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib9","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1017\/S003329170600777X","article-title":"Behavioral and neuropsychological correlates of frontal lobe features in dementia","volume":"36","author":"Engelborghs","year":"2006","journal-title":"Psychol. Med"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/gps.1341","article-title":"Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies","volume":"20","author":"Gauthier","year":"2005","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/gps.1984","article-title":"Alzheimer's disease in real life\u2014the dementia carer's survey","volume":"23","author":"Georges","year":"2008","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib13","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1073\/pnas.85.11.4051","article-title":"Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau","volume":"85","author":"Goedert","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1471-4159.1995.65020732.x","article-title":"Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain","volume":"65","author":"Gong","year":"1995","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1471-4159.1993.tb03603.x","article-title":"Phosphoprotein phosphatase activities in Alzheimer disease brain","volume":"61","author":"Gong","year":"1993","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1471-4159.1994.62020803.x","article-title":"Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin)","volume":"62","author":"Gong","year":"1994","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ana.410330113","article-title":"Okadaic acid induces hyperphosphorylated forms of tau protein in human brain slices","volume":"33","author":"Harris","year":"1993","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S0033291700032888","article-title":"The Present Behavioral Examination (PBE): the development of an interview to measure current behavioral abnormalities","volume":"22","author":"Hope","year":"1992","journal-title":"Psychol. Med"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib19","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/(SICI)1099-1166(199711)12:11<1074::AID-GPS696>3.0.CO;2-B","article-title":"Behavior changes in dementia 2: are there behavioral syndromes?","volume":"12","author":"Hope","year":"1997","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/(SICI)1099-1166(199711)12:11<1062::AID-GPS675>3.0.CO;2-N","article-title":"Behavior changes in dementia 1: point of entry data of a prospective study","volume":"12","author":"Hope","year":"1997","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-009-0486-3","article-title":"Mechanisms of tau-induced neurodegeneration","volume":"118","author":"Iqbal","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0896-6273(00)81127-7","article-title":"Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform","volume":"24","author":"Ishihara","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/01.WNL.0000110315.26026.EF","article-title":"Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD","volume":"62","author":"Jack","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3233\/JAD-2002-4505","article-title":"Tau, where are we now?","volume":"4","author":"Johnson","year":"2002","journal-title":"J. Alzheimers Dis"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/197192b0","article-title":"Paired helical filaments in electron microscopy of Alzheimer's disease","volume":"197","author":"Kidd","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2006.03935.x","article-title":"Down regulation of vesicular glutamate transporters precede cell loss and pathology in Alzheimer's disease","volume":"98","author":"Kirvell","year":"2006","journal-title":"J. Neurochem"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2990.2006.00795.x","article-title":"Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration","volume":"33","author":"Leroy","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.febslet.2004.04.047","article-title":"Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration","volume":"566","author":"Li","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib29","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","article-title":"Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation","volume":"22","author":"Liu","year":"2005","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib30","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0960-9822(00)00246-3","article-title":"Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells","volume":"4","author":"Lovestone","year":"1994","journal-title":"Curr. Biol"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrd2111","article-title":"Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases","volume":"6","author":"Mazanetz","year":"2007","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib32","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1212\/WNL.55.10.1460","article-title":"Cholinergic deficits contribute to behavioral disturbance in patients with dementia","volume":"55","author":"Minger","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The consortium to establish a registry for Alzheimer's disease (CERAD)","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-5793(97)00688-1","article-title":"Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons","volume":"411","author":"Munoz-Montano","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/002383099200500108","article-title":"Incontinence and troublesome behaviors predict institutionalisation in dementia","volume":"5","author":"O'Donnell","year":"1992","journal-title":"J. Geriatr. Psychiatry Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/FBP.0b013e32833da5da","article-title":"Intracellular pathways underlying the effects of lithium","volume":"21","author":"Pasquali","year":"2010","journal-title":"Behav. Pharmacol"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/156720510791162340","article-title":"Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD","volume":"7","author":"Sabbagh","year":"2010","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000074080","article-title":"Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction","volume":"17","author":"Senanarong","year":"2004","journal-title":"Dement. Geriatr. Cogn. Disord"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib39","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1176\/ajp.147.8.1049","article-title":"Psychiatric-symptoms and nursing-home placement of patients with Alzheimer's disease","volume":"147","author":"Steele","year":"1990","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.01.015_bib40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ana.72","article-title":"Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease","volume":"49","author":"Tekin","year":"2001","journal-title":"Ann. Neurol"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745801200036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745801200036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T22:27:34Z","timestamp":1588804054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019745801200036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S019745801200036X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.01.015","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}